BioNTech SE (BNTX)
108.23
+6.09
(+5.96%)
USD |
NASDAQ |
Nov 21, 16:00
107.72
-0.51
(-0.47%)
After-Hours: 07:27
BioNTech Total Assets (Quarterly): 25.02B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 25.02B |
| June 30, 2024 | 23.84B |
| March 31, 2024 | 24.04B |
| December 31, 2023 | 25.43B |
| September 30, 2023 | 23.51B |
| June 30, 2023 | 24.15B |
| March 31, 2023 | 24.08B |
| December 31, 2022 | 24.96B |
| September 30, 2022 | 22.27B |
| June 30, 2022 | 22.10B |
| March 31, 2022 | 22.66B |
| December 31, 2021 | 17.92B |
| Date | Value |
|---|---|
| September 30, 2021 | 16.51B |
| June 30, 2021 | 10.89B |
| March 31, 2021 | 4.929B |
| December 31, 2020 | 2.852B |
| September 30, 2020 | 1.701B |
| June 30, 2020 | 1.095B |
| March 31, 2020 | 807.58M |
| December 31, 2019 | 893.50M |
| September 30, 2019 | 807.89M |
| June 30, 2019 | 821.33M |
| December 31, 2018 | 746.95M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
807.58M
Minimum
Mar 2020
25.43B
Maximum
Dec 2023
15.98B
Average
22.19B
Median
Total Assets (Quarterly) Benchmarks
| Novavax Inc | 1.712B |
| DBV Technologies SA | 93.06M |
| Akari Therapeutics PLC | 2.734M |
| Biodexa Pharmaceuticals PLC | 17.67M |
| NuCana PLC | 25.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.671B |
| Shareholders Equity (Quarterly) | 21.35B |
| Debt to Equity Ratio | 0.0127 |
| Current Ratio | 7.328 |
| Net Debt Paydown Yield | -0.03% |